Review Article
Gallbladder Cancer in the 21st Century
Table 5
Results of three phase 2 trials which exclusively evaluated efficacy of chemotherapy in patients with advanced gall bladder cancer.
| Regimen | Number of patients | Response rate (%) | Median overall survival |
| Gemcitabine monotherapy [107] | 26 | 36 | 30 weeks | Gemcitabine and cisplatin [106] | 30 | 37 | 20 weeks | Gemcitabine and cisplatin [108] | 42 | 48 | 7 months |
|
|
Modified from [2].
|